CIK 1263048
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q2. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
Signed this manager's latest 13F (2025-Q3). The filing's authorized signatory — frequently a compliance officer, general counsel, or CFO — not necessarily the portfolio manager or firm leadership.
| Name | Role (as filed) | Departed after | Now at (if tracked) |
|---|---|---|---|
| EVNIN, LUKE, BASIL | SENIOR ADVISOR · MANAGING DIRECTOR | 2024-06 | — not seen at a tracked firm |
| LAGUERRE, KRISTEN, LEE | PARTNER, FINANCE AND OPERATIONS · CHIEF FINANCIAL OFFICER AND CHIEF OPERATIONS OFFICER · MANAGING DIRECTOR, FINANCE | 2024-06 | MPM BIOIMPACT LLC |
| HURWITZ, EDWARD, MARTIN | MANAGING DIRECTOR | 2022-11 | — not seen at a tracked firm |
| CRISPEN, JEFF, WILLIAM | CHIEF COMPLIANCE OFFICER | 2022-03 | — not seen at a tracked firm |
| MCGRATH, NICHOLAS, MYLES |
| GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER |
| 2021-03 |
| — not seen at a tracked firm |
| REED, SARAH | CHIEF OPERATING OFFICER AND GENERAL COUNSEL | 2019-03 | — not seen at a tracked firm |
| Cauley, Lauren | CHIEF FINANCIAL OFFICER | 2019-03 | — not seen at a tracked firm |
| RUBIN, HOWARD, BRUCE | CHIEF COMPLIANCE OFFICER | 2019-03 | — not seen at a tracked firm |
| GEESAMAN, BARD, JAMES | MANAGING DIRECTOR · CHIEF COMPLIANCE OFFICER | 2018-07 | — not seen at a tracked firm |
| SCOPA, JAMES, PAUL | MANAGING DIRECTOR | 2017-03 | — not seen at a tracked firm |
Named owners/officers on a past Form ADV Schedule A who are gone from the firm's latest filing. “Departed after” is the last dated filing they appear on. A landing shows only when the destination is another SEC-registered adviser we track.
